German industrial conglomerate Siemens AG is looking to divest its dental business, but plans to retain the bulk of its Medical Engineering Group, contrary to rumors that have surfaced in the European press recently.Siemens reported April 21 that it is
German industrial conglomerate Siemens AG is looking to divest its dental business, but plans to retain the bulk of its Medical Engineering Group, contrary to rumors that have surfaced in the European press recently.
Siemens reported April 21 that it is looking for a merger partner or acquirer for its Dental Systems division in Bensheim, Germany, and Pelton & Crane subsidiary in Charlotte, NC. Siemens said the move was part of the group's ongoing effort to improve its competitiveness and cost structure (SCAN 3/19/97).
The company emphasized that it does not intend to divest the rest of Medical Engineering, however.
"There is no reason for deleting Medical Engineering from our core businesses," said Heinrich von Pierer, chairman of Siemens AG. "It is obvious that our medical portfolios...are subject to permanent development."
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.